MeadowBrook Investment Advisors LLC Takes Position in The Procter & Gamble Company (NYSE:PG)

MeadowBrook Investment Advisors LLC purchased a new stake in The Procter & Gamble Company (NYSE:PGFree Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 227 shares of the company’s stock, valued at approximately $33,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. AllGen Financial Advisors Inc. lifted its stake in shares of Procter & Gamble by 0.3% in the fourth quarter. AllGen Financial Advisors Inc. now owns 20,679 shares of the company’s stock valued at $3,030,000 after buying an additional 68 shares during the period. Metis Global Partners LLC lifted its stake in shares of Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after buying an additional 15,599 shares during the period. TCI Wealth Advisors Inc. lifted its stake in shares of Procter & Gamble by 16.6% in the fourth quarter. TCI Wealth Advisors Inc. now owns 15,164 shares of the company’s stock valued at $2,222,000 after buying an additional 2,157 shares during the period. W.H. Cornerstone Investments Inc. lifted its stake in shares of Procter & Gamble by 14.4% in the fourth quarter. W.H. Cornerstone Investments Inc. now owns 8,511 shares of the company’s stock valued at $1,247,000 after buying an additional 1,074 shares during the period. Finally, Connecticut Wealth Management LLC lifted its stake in Procter & Gamble by 1.3% during the fourth quarter. Connecticut Wealth Management LLC now owns 16,599 shares of the company’s stock worth $2,432,000 after purchasing an additional 210 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,859 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the sale, the chief operating officer now directly owns 9,739 shares of the company’s stock, valued at approximately $1,605,961.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 31,859 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the completion of the transaction, the chief operating officer now owns 9,739 shares in the company, valued at approximately $1,605,961.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 118,724 shares of company stock valued at $19,312,729. 0.17% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. UBS Group raised their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research note on Wednesday, January 24th. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price for the company. Wells Fargo & Company lifted their target price on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. Finally, Argus lifted their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Seven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Read Our Latest Stock Report on Procter & Gamble

Procter & Gamble Trading Up 0.5 %

PG traded up $0.80 during trading on Tuesday, reaching $165.24. 2,602,932 shares of the company’s stock were exchanged, compared to its average volume of 6,850,097. The company’s fifty day moving average price is $160.10 and its 200-day moving average price is $154.37. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $166.04. The firm has a market capitalization of $389.99 billion, a PE ratio of 27.01, a P/E/G ratio of 3.34 and a beta of 0.43.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same quarter in the previous year, the business earned $1.37 EPS. The firm’s revenue was up .6% on a year-over-year basis. As a group, equities analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a $1.0065 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s payout ratio is currently 65.85%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.